- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Scholar Rock Holding Corp (SRRK)
Scholar Rock Holding Corp stock price live, this page displays NASDAQ SRRK stock exchange data. View the SRRK premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Scholar Rock Holding Corp real time stock price chart below.
What Is the Scholar Rock Holding Corp Stock Price Today?
The Scholar Rock Holding Corp stock price today is 34.71.
What Is the Stock Symbol for Scholar Rock Holding Corp?
The stock symbol for Scholar Rock Holding Corp is "SRRK."
What Stock Exchange Does Scholar Rock Holding Corp Trade On?
Scholar Rock Holding Corp is listed and trades on the NASDAQ stock exchange.
Is Scholar Rock Holding Corp a Good Stock to Buy?
Determining whether Scholar Rock Holding Corp—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the SRRK quote. (ISIN: US80706P1030)
What Is the Scholar Rock Holding Corp Stock Price Today?
The Scholar Rock Holding Corp stock price today is 34.71.
What Is the Stock Symbol for Scholar Rock Holding Corp?
The stock symbol for Scholar Rock Holding Corp is "SRRK."
What Stock Exchange Does Scholar Rock Holding Corp Trade On?
Scholar Rock Holding Corp is listed and trades on the NASDAQ stock exchange.
Is Scholar Rock Holding Corp a Good Stock to Buy?
Determining whether Scholar Rock Holding Corp—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the SRRK quote. (ISIN: US80706P1030)
34.71
+0.11(+0.32%)
Closed
After Hours
34.72+0.01(+0.03%)
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
33.77
35.21
52 wk Range
6.76
46.98
SRRK Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
33.7735.21
52 wk Range
6.7646.98
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
SRRK Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceFair Price
Upside
Technical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
50.50
Upside
+45.49%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
3 analysts have revised their earnings downwards for the upcoming period
Scholar Rock Holding Corp Company Profile
Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery, development, and delivery of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company develops Apitegromab, an inhibitor of the activation of myostatin that is in Phase 3 clinical trial for the treatment of spinal muscular atrophy; and SRK-181, which has completed Phase 1 clinical trials for the treatment of cancers that are resistant to checkpoint inhibitor therapies, such as anti-PD-1 or anti-PD-L1 antibody therapies. It is developing a pipeline of product candidates to deliver novel therapies to treat a range of serious diseases, including neuromuscular disorders, cardiometabolic disorders, cancer, fibrosis, and iron-restricted anemia. Scholar Rock Holding Corporation was founded in 2012 and is headquartered in Cambridge, Massachusetts.
Scholar Rock Holding Corp SWOT Analysis
Pivotal Trial Awaits | Scholar Rock's SAPPHIRE trial for apitegromab in SMA nears completion, with potential to revolutionize treatment and drive significant market valuation |
Oncology Breakthrough | SRK-181 shows promise in overcoming resistance to immune checkpoint inhibitors, addressing a critical challenge in cancer treatment |
Expanding Horizons | Scholar Rock ventures into the lucrative obesity market with EMBRAZE trial and SRK-439, diversifying its pipeline beyond core focus areas |
Financial Outlook | Analyst targets range from $29 to $31, with potential for significant upside if pivotal trials succeed, despite current lack of revenue-generating assets |
Scholar Rock Holding Corp Earnings Call Summary for Q4/2024
- Q4 2024 EPS of -$2.47 missed forecast of -$0.58, but stock rose 1.84% in premarket trading
- Company preparing for U.S. launch of SMA treatment in Q4 2025, EU launch in 2026
- IND filing for SRK-439 cardiometabolic treatment planned for Q3 2025
- Expanding neuromuscular franchise, exploring new indications like DMD, FSHD, and ALS
- Analyst price targets range $39-$57; company not expected to achieve profitability this year
Last Updated: 28/02/2025, 01:28 am
Read Full TranscriptCompare SRRK to Peers and Sector
Metrics to compare | SRRK | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipSRRKPeersSector | |
|---|---|---|---|---|
P/E Ratio | −13.2x | −1.0x | −0.5x | |
PEG Ratio | 0.65 | −0.01 | 0.00 | |
Price/Book | 8.9x | 1.2x | 2.6x | |
Price / LTM Sales | - | 6.6x | 3.0x | |
Upside (Analyst Target) | 45.0% | 292.6% | 56.4% | |
Fair Value Upside | Unlock | 25.6% | 9.9% | Unlock |
Analyst Ratings
9 Buy
0 Hold
0 Sell
Ratings:
9 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 50.50
(+45.49% Upside)
Earnings
Latest Release
Feb 27, 2025
EPS / Forecast
-2.47 / -0.58
Revenue / Forecast
-- / --
People Also Watch
FAQ
What Is the Scholar Rock (SRRK) Stock Price Today?
The Scholar Rock stock price today is 34.71
What Stock Exchange Does Scholar Rock Trade On?
Scholar Rock is listed and trades on the NASDAQ stock exchange.
What Is the Stock Symbol for Scholar Rock?
The stock symbol for Scholar Rock is "SRRK."
What Is the Scholar Rock Market Cap?
As of today, Scholar Rock market cap is 3.27B.
What is Scholar Rock Earnings Per Share?
The Scholar Rock EPS is -2.63.
What Is the Next Scholar Rock Earnings Date?
Scholar Rock will release its next earnings report on 07 May 2025.
From a Technical Analysis Perspective, Is SRRK a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.